改善艾滋病毒和慢性疼痛患者的睡眠:对失眠短期行为治疗的试点研究
Shameka L Cody1, Daniel A Kusko2, Cesar E Gonzalez3
1Capstone College of Nursing, University of Alabama, Tuscaloosa, AL, USA.
Behavioral sleep medicine
|September 8, 2024
概括
简短的失眠行为治疗 (BBTI) 显著改善了艾滋病毒感染者的失眠和疼痛. 这种通过电话进行的干预为管理这些常见症状提供了有希望的解决方案.
科学领域:
- 医学研究 医学研究
- 心理学 心理学 心理学
- 公共卫生 公共卫生
背景情况:
- 失眠和慢性疼痛在艾滋病毒感染者中很普遍.
- 睡眠质量差经常与慢性疼痛严重程度的增加有关.
- 由于提供者短缺和会议长度,艾滋病毒感染者对传统的失眠认知行为疗法 (CBT-I) 的访问是有限的.
研究的目的:
- 调查短暂行为治疗失眠 (BBTI) 在改善艾滋病毒感染者睡眠和疼痛结果方面的疗效.
- 为解决与标准失眠治疗相关的可访问性障碍,在这个人群中.
主要方法:
- 一项试点研究涉及10名艾滋病毒感染者和慢性疼痛的成年人,他们接受了为期4周的电话BBTI计划.
- 对照组 (n=10) 接受了简短的正念训练 (BMT).
- 失眠严重程度和疼痛干扰分别使用失眠严重程度指数和简短疼痛库存进行测量.
主要成果:
- 对于失眠严重程度,观察到干预和时间之间的显著相互作用,BBTI组在治疗后和一个月后随访时与 BMT组相比显示出明显的改善.
- 在BBTI小组中,从干预前到干预后,疼痛干扰的显著改善,超过了BMT小组的表现.
- 对于两个主要结果,统计学显著性得到实现 (p < .05).
结论:
- 简短的失眠行为治疗 (BBTI) 有效地改善了艾滋病毒感染者的失眠症状,治疗后长达一个月.
- 初步发现表明,BBTI也可能对这一群体的疼痛结果产生积极影响.
- 通过电话传递的BBTI提供了一个可行的和可访问的治疗选择,用于管理艾滋病毒感染者的伴随性失眠和疼痛.
相关概念视频
Insomnia
81
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
81
Management of Insomnia
235
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
235
Sedatives and Hypnotics Drugs: Miscellaneous Agents
159
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
159
Insufficient Sleep and Sleep Deprivation
137
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
137
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
CNS Depressants: Barbiturates and Benzodiazepines
232
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
232


